ATE526960T1 - Arzneimittel zur behandlung von grippe - Google Patents

Arzneimittel zur behandlung von grippe

Info

Publication number
ATE526960T1
ATE526960T1 AT08721158T AT08721158T ATE526960T1 AT E526960 T1 ATE526960 T1 AT E526960T1 AT 08721158 T AT08721158 T AT 08721158T AT 08721158 T AT08721158 T AT 08721158T AT E526960 T1 ATE526960 T1 AT E526960T1
Authority
AT
Austria
Prior art keywords
products used
medicinal products
treat flu
influenza
prophylactic
Prior art date
Application number
AT08721158T
Other languages
English (en)
Inventor
Makoto Yamashita
Yoshihiro Kawaoka
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE526960T1 publication Critical patent/ATE526960T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08721158T 2007-03-07 2008-03-03 Arzneimittel zur behandlung von grippe ATE526960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007056872 2007-03-07
PCT/JP2008/053738 WO2008108323A1 (ja) 2007-03-07 2008-03-03 インフルエンザ治療剤

Publications (1)

Publication Number Publication Date
ATE526960T1 true ATE526960T1 (de) 2011-10-15

Family

ID=39738201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08721158T ATE526960T1 (de) 2007-03-07 2008-03-03 Arzneimittel zur behandlung von grippe

Country Status (16)

Country Link
US (2) US20100204314A1 (de)
EP (1) EP2123271B1 (de)
JP (2) JP5286251B2 (de)
KR (1) KR101473028B1 (de)
CN (1) CN101715343B (de)
AT (1) ATE526960T1 (de)
CA (1) CA2680415A1 (de)
CY (1) CY1112201T1 (de)
DK (1) DK2123271T3 (de)
ES (1) ES2372996T3 (de)
HR (1) HRP20110861T1 (de)
PL (1) PL2123271T3 (de)
PT (1) PT2123271E (de)
SI (1) SI2123271T1 (de)
TW (1) TWI424841B (de)
WO (1) WO2008108323A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
EP2568976B1 (de) * 2010-05-10 2015-09-30 Academia Sinica Zanamivir-phosphinat-kongenere mit antigrippewirkung und bestimmung der oseltamivir-empfänglichkeit von influenzaviren
ES2640001T3 (es) * 2011-12-16 2017-10-31 Daiichi Sankyo Company, Limited Procedimiento de producción de un derivado del ácido neuramínico
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
EP3129767B1 (de) 2014-03-27 2021-09-01 Academia Sinica Reaktive markierungsverbindungen und ihre verwendungen
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
DK3149045T3 (da) 2014-05-27 2023-03-06 Academia Sinica Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗ＴＮＦα糖操作抗体群およびその使用
EP3191500A4 (de) 2014-09-08 2018-04-11 Academia Sinica Aktivierung menschlicher inkt-zellen mithilfe von glykolipiden
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10342858B2 (en) 2015-01-24 2019-07-09 Academia Sinica Glycan conjugates and methods of use thereof
AU2017231749A1 (en) 2016-03-08 2018-09-20 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
AU2018349244B2 (en) * 2017-10-11 2024-08-22 Lifescience As N-acetylneuraminic acid compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6451766B1 (en) * 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP3209946B2 (ja) * 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
US6340702B1 (en) * 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP4151800B2 (ja) 1996-08-13 2008-09-17 第一三共株式会社 ノイラミン酸化合物
JP3920041B2 (ja) * 2000-04-25 2007-05-30 三共株式会社 ノイラミン酸化合物の水和物及び結晶
TWI291462B (en) * 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
DE602006003600D1 (de) 2005-08-22 2008-12-24 Delphi Tech Inc Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad

Also Published As

Publication number Publication date
DK2123271T3 (da) 2012-01-23
KR20090129414A (ko) 2009-12-16
SI2123271T1 (sl) 2012-05-31
CY1112201T1 (el) 2015-12-09
PT2123271E (pt) 2011-12-20
TW200848018A (en) 2008-12-16
US20140018418A1 (en) 2014-01-16
JPWO2008108323A1 (ja) 2010-06-17
TWI424841B (zh) 2014-02-01
KR101473028B1 (ko) 2014-12-15
CA2680415A1 (en) 2008-09-12
EP2123271B1 (de) 2011-10-05
CN101715343B (zh) 2012-09-26
PL2123271T3 (pl) 2012-03-30
CN101715343A (zh) 2010-05-26
EP2123271A1 (de) 2009-11-25
ES2372996T3 (es) 2012-01-30
EP2123271A4 (de) 2010-03-17
US20100204314A1 (en) 2010-08-12
HK1137142A1 (en) 2010-07-23
JP2013139483A (ja) 2013-07-18
JP5286251B2 (ja) 2013-09-11
HRP20110861T1 (hr) 2011-12-31
JP6012076B2 (ja) 2016-10-25
WO2008108323A1 (ja) 2008-09-12

Similar Documents

Publication Publication Date Title
EP2123271A4 (de) Arzneimittel zur behandlung von grippe
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
BRPI1009637A2 (pt) composto, composição e uso de um composto
ATE496920T1 (de) Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
MA38865A1 (fr) Formulation comprenant un agent hypolipidémiant
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2011025982A3 (en) Tetracycline compounds
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
WO2009051223A1 (ja) 白内障処置のための医薬組成物
SA112330457B1 (ar) مشتقات فينيل- ايزواوكسازول وعملية تحضيرها
BRPI0512970A (pt) prodrogas de inibidores da hiv protease
SE0303480D0 (sv) Benzofuranes
NO20064344L (no) Caspaseinhibitorer og anvendelser derav
NO20081587L (no) Aerosolformulering for inhalering
EA201190003A1 (ru) Производные хроменона в качестве trpv3 антагонистов
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
NO20083352L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
AU2003216965A1 (en) Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
BR0312615A (pt) Compostos úteis como inibidores de metaloproteinases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2123271

Country of ref document: EP